Grey Matters Health (GREY) AI Stock Analysis

Grey Matters Health

(CNQX:GREY)

Select Model

Rating:41Neutral

Price Target:CAD 0.36▲(6.76% Upside)

Action:reiterated

Date:10/03/26

The overall score is driven primarily by a pre-revenue financial profile with deepening losses and negative cash flows despite a debt-free balance sheet, while sustained technical weakness and oversold momentum suggest continued price pressure and the lack of earnings or dividends provides limited valuation support.

Positive Factors

Debt-free balance sheetNo debt reduces interest expense and near-term repayment pressure, preserving financial flexibility while the company develops its VR healthcare and wellness offerings. This provides a stronger base for funding operations than a similarly loss-making business carrying material leverage.

Negative Factors

No demonstrated revenue baseZero reported revenue means the business has not yet demonstrated commercial traction or a repeatable monetization engine for its VR applications. Without revenue scale, future growth remains dependent on converting healthcare and wellness offerings into paying demand.

Grey Matters Health (GREY) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 2.14M
Dividend Yield: ―
Average Volume (3M): 12.64K
Price to Earnings (P/E): -0.1
Beta (1Y): 0.15
Revenue Growth: ―
EPS Growth: 17.84%
Country: Canada
Employees: 5
Sector: General
Sector Strength: 55
Industry: Biotechnology

Grey Matters Health Business Overview & Revenue Model

Company Description

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney dis...

Grey Matters Health Financial Statement Overview

Summary

Financial performance is very weak, with no revenue, escalating net losses to -$1.9M in TTM, and persistently negative operating cash flow, partly offset by a debt-free balance sheet and modest equity growth.

Income Statement

5Very Negative

Balance Sheet

75Positive

Cash Flow

15Very Negative

Grey Matters Health Technical Analysis

Technical Analysis SentimentNegative

Last Price0.34

Price Trends

50DMA0.44Negative

100DMA0.44Negative

200DMA0.44Negative

Market Momentum

MACD-0.03Positive

RSI42.55Neutral

STOCH18.22Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GREY, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.37, below the 50-day MA of 0.44, and below the 200-day MA of 0.44, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 42.55 is Neutral, neither overbought nor oversold. The STOCH value of 18.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GREY.

Grey Matters Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TSE:GREY against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TSE:GREY	41Neutral	CAD 3.03M	-0.08	-92.73%	―	―	17.84%

* General Sector Average

Performance Comparison

TSE:GREY and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:GREY	Grey Matters Health Inc	0.34	-0.46	-57.45%
TSE:RKV	Rakovina Therapeutics Inc	0.18	-0.02	-7.50%
TSE:IBO	Universal Ibogaine Inc	0.01	0.00	0.00%
TSE:MBIO	Mindbio Therapeutics Corp.	0.10	-1.90	-94.75%
TSE:NURL	Neural Therapeutics Inc.	0.01	-0.01	-50.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 03, 2026

Grey Matters Health AI Stock Analysis